Evidence map›Paper›PMID 30678027›Full record

ArticleMolecules (Basel, Switzerland)2019

Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA.

Elodie Morel, Claire Beauvineau, Delphine Naud-Martin, Corinne Landras-Guetta, Daniela Verga, Deepanjan Ghosh, Sylvain Achelle, Florence Mahuteau-Betzer, Sophie Bombard, Marie-Paule Teulade-Fichou

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. The arylbipyridine platinum (II) complex increases the level of ROS and induces lipid peroxidation in glioblastoma cells.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in medicine · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. A study of Pt(II)-phenanthroline complex interactions with double-stranded and G-quadruplex DNA by ESI-MS, circular dichroism, and computational docking.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Elodie MorelInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. emc.morel@gmail.com.
Claire BeauvineauInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. Claire.Beauvineau@curie.fr.
Delphine Naud-MartinInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. Delphine.Naud@curie.fr.
Corinne Landras-GuettaInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. Corinne.guetta@curie.fr.
Daniela VergaInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. Daniela.Verga@curie.fr.
Deepanjan GhoshInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. Deepanjan.ghosh@curie.fr.
Sylvain AchelleInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. sylvain.achelle@univ-rennes1.fr.
Florence Mahuteau-BetzerInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. Florence.Mahuteau@curie.fr.
Sophie BombardInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. sophie.bombard@curie.fr.
Marie-Paule Teulade-FichouInstitut Curie, PSL Research University, CNRS-UMR 9187, INSERM U1196, F-91405 Orsay, France. marie-paule.teulade-fichou@curie.fr.
Université Paris-Sud · FR

Funding

Association pour la Recherche contre le Cancer 4835
6 · The paper itself

Abstract

Guanine-rich DNA can form four-stranded structures called G-quadruplexes (G4s) that can regulate many biological processes. Metal complexes have shown high affinity and selectivity toward the quadruplex structure. Here, we report the comparison of a panel of platinum (II) complexes for quadruplex DNA selective recognition by exploring the aromatic core around terpyridine derivatives. Their affinity and selectivity towards G4 structures of various topologies have been evaluated by FRET-melting (Fluorescence Resonance Energy Transfert-melting) and Fluorescent Intercalator Displacement (FID) assays, the latter performed by using three different fluorescent probes (Thiazole Orange (TO), TO-PRO-3, and PhenDV). Their ability to bind covalently to the c-myc G4 structure in vitro and their cytotoxicity potential in two ovarian cancerous cell lines were established. Our results show that the aromatic surface of the metallic ligands governs, in vitro, their affinity, their selectivity for the G4 over the duplex structures, and platination efficiency. However, the structural modifications do not allow significant discrimination among the different G4 topologies. Moreover, all compounds were tested on ovarian cancer cell lines and normal cell lines and were all able to overcome cisplatin resistance highlighting their interest as new anticancer drugs.

Indexed as

Anticarcinogenic AgentsCisplatinDrug Resistance, NeoplasmFemaleFluorescence Resonance Energy TransferFluorescent DyesG-QuadruplexesHumansLigandsNucleic Acid ConformationOvarian NeoplasmsPlatinumProto-Oncogene Proteins c-mycPyridinesAnticarcinogenic AgentsCisplatinFluorescent DyesLigandsMYC protein, humanPlatinumProto-Oncogene Proteins c-mycPyridinesG-quadruplexterpyridine platinum complexes

Identifiers

PMID30678027
PMCPMC6385020
OpenAlexW2911821870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.